Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives.

Usman, M B; Bhardwaj, S; Roychoudhury, S; Kumar, D; Alexiou, A; Kumar, P; Ambasta, R K; Prasher, P; Shukla, S; Upadhye, V; Khan, F A; Awasthi, R; Shastri, M D; Singh, S K; Gupta, G; Chellappan, D K; Dua, K; Jha, S K; Ruokolainen, J; Kesari, K K; Ojha, S; Jha, N K

Usman, M B; Bhardwaj, S; Roychoudhury, S; Kumar, D; Alexiou, A; Kumar, P; Ambasta, R K; Prasher, P; Shukla, S; Upadhye, V; Khan, F A; Awasthi, R; Shastri, M D; Singh, S K; Gupta, G; Chellappan, D K; Dua, K; Jha, S K; Ruokolainen, J; Kesari, K K; Ojha, S; Jha, N K.

Afiliación

Usman MB; Dr. Niraj Kumar Jha, Assistant Professor, Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Knowledge Park III, Greater Noida, Uttar Pradesh-201310, India, Email: nirajkumarjha2011@gmail.com; niraj.jha@sharda.ac.in, Tel: +91-7488019194, ORCID: 0000-0001-9486-4069; Dr. Shreesh Ojha, Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, UAE University, PO Box - 17666, Al Ain, UAE, E-mail: shreeshojha@uaeu.a

J Prev Alzheimers Dis ; 8(4): 534-551, 2021.

Article en En | MEDLINE | ID: mdl-34585229

Asunto(s)

Enfermedad de Alzheimer/tratamiento farmacológico; Vacunas contra el Alzheimer; Anticuerpos Monoclonales Humanizados/uso terapéutico; Inmunoterapia; Disfunción Cognitiva/prevención & control; Humanos; Placa Amiloide/patología

Palabras clave

Alzheimer's disease; active immunotherapy; amyloid plaque; monoclonal antibody; passive immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Alzheimer / Enfermedad de Alzheimer / Anticuerpos Monoclonales Humanizados / Inmunoterapia Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Prev Alzheimers Dis Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google